A method of retrieving sequence-verified deoxyribonucleic acid (DNA) includes positioning a sequence-verified DNA molecule on a microelectromechanical systems (MEMS) substrate. The MEMS substrate includes an electrostatic actuator and the sequence-verified DNA molecule is positioned adjacent to a moving element. The method also includes applying a voltage between the moving element and a stator to cause a motion of the moving element, thereby ejecting the sequence-verified DNA molecule from the MEMS substrate.
This invention has been likened to a laser printer for DNA.
Sources:
- September 1, 2015. Austen Heinz. United States Patent: 9121825 – Methods and apparatuses for MEMs based recovery of sequence verified DNA. 9121825, filed December 21, 2012, and issued September 1, 2015. Assignee: Cambrian Genomics, Inc..
https://patents.google.com/patent/US9121825B2,
Local copy.
Patent. - “Austen J Heinz from Pinehurst, NC.” Inforver.
https://inforver.com/view/Austen-Heinz-EhAIHP.
General Website Link.
Related:
- November 13, 2007. Jason Barron, Bradley R. Ringeisen, Heungsoo Kim, and Peter Wu. United States Patent: 7294367 – Biological laser printing via indirect photon-biomaterial interactions. 7294367, filed June 6, 2003, and issued November 13, 2007. Assignee: The United States of America as represented by the Secretary of the Navy.
https://patents.google.com/patent/US7294367B2.
Patent. - “Charles L. Buchanan Inventions, Patents and Patent Applications.” JUSTIA Patents.
https://patents.justia.com/inventor/charles-l-buchanan.
Patent. - November 10, 2020. Fred Lambert. “Elon Musk: Tesla’s RNA Vaccine Printer for CureVac Is Going to Be ‘Important Product for the World.’” Electrek.
https://electrek.co/2020/11/10/elon-musk-tesla-rna-vaccine-printer-curevac-important-product-world/.
General Website Link.
See also, on this site:
When I did a search for 20140008223 on the USPTO site, three other documents came up as well, all filed by Charles L. Buchanan. It does not appear that these patents have been issued yet.